Morning Buzz: Merck & Co. Inc. (NYSE:MRK), Hewlett-Packard Company (NYSE:HPQ), Conatus Pharmaceuticals Inc. (NASDAQ:CNAT), Verizon Communications Inc. (NYSE:VZ), Nxstage Medical, Inc. (NASDAQ:NXTM)

Merck & Co. Inc. (NYSE:MRK) ended the last trading day at $57.71. Company weekly volatility is calculated as 1.30% and price to cash ratio as 10.45. Merck & Co. Inc. (NYSE:MRK) showed a weekly performance of -1.17%. The European Commission said on Monday it had approved Merck & Co. Inc. (NYSE:MRK)’s $17 billion acquisition of Sigma-Aldrich Corp following the U.S. company’s pledges to sell assets in Germany.

Hewlett-Packard Company (NYSE:HPQ) shares moved down -0.19% in last trading session and ended the day at $31.65. HPQ Gross Margin is 24.00% and its return on assets is 4.60%. Hewlett-Packard Company (NYSE:HPQ) quarterly performance is -1.88%. On 10 June, Hewlett Packard Co. (NYSE:HPQ) has reached a $100-million settlement over a class action lawsuit pertaining to its controversial acquisition of British software firm Autonomy Corp in 2011. The agreement with the lead plaintiff of the lawsuit PGGM Vermogensbeheer BV is related to the impairment charge taken by HP following the acquisition.

On 16 June, Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) shares moved down -2.11% and was closed at $5.58. CNAT EPS growth in last 5 year was 0.00%. Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) year to date (YTD) performance is -20.29%. On 12 June, Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) hired Jean Chan as vice president, clinical development.

Verizon Communications Inc. (NYSE:VZ) shares advanced 0.89% in last trading session and ended the day at $47.42. VZ Gross Margin is 60.40% and its return on assets is 4.30%. Verizon Communications Inc. (NYSE:VZ) quarterly performance is -2.03%. Sony Mobile Communications and Verizon Communications Inc. (NYSE:VZ) have announced that the Sony Xperia Z4v smartphone will be available in the US this summer exclusively from Verizon Wireless.

Nxstage Medical, Inc. (NASDAQ:NXTM) shares moved down -0.13% in last trading session and ended the day at $15.31. NXTM Gross Margin is 37.90% and its return on assets is -7.90%. Nxstage Medical, Inc. (NASDAQ:NXTM) quarterly performance is -12.16%. On 10 June, NxStage Medical Inc. (NASDAQ:NXTM) has released an infographic
that demonstrates how California can save 221 million gallons of water annually by transitioning just 20% of its in-center dialysis patients to home hemodialysis with the NxStage System One. According to NxStage, California uses 1.2 billion gallons a year on in-center dialysis treatments.

Leave a Reply

Your email address will not be published. Required fields are marked *